Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre NIS Retrospective Study to Know the Prevalence of HER2- Low,Clinical Characteristics,Treatment Patterns,Associated Outcome in Patient With HER2-negative in Metastatic Breast Cancer Who Progressed on Systemic Anticancer Therapy

NCT06131424 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06131424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06131424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre NIS Retrospective Study to Know the Prevalence of HER2- Low,Clinical Characteristics,Treatment Patterns,Associated Outcome in Patient With HER2-negative in Metastatic Breast Cancer Who Progressed on Systemic Anticancer Therapy
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 23, 2024
Completion date
May 19, 2025
Enrollment
1,151 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

her2-negative